Alkem Laboratories Limited (NSE:ALKEM)
India · Delayed Price · Currency is INR 5,216.50
-19.50 (-0.37%)
Nov 4, 2026, 3:29 PM IST
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 623.71 billion as of November 4, 2026. It is the 2,868th most valuable company in the world and the 166th biggest in India. Its market cap has decreased by 7.32% in one year.
Market Cap
623.71B
Enterprise Value
608.86B
Revenue
150.81B
Global Rank
Country Rank
#166 India
PE Ratio
28.91
ChartMarket Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 623.71B, an increase of 277.54%. That is a compound annual growth rate of 13.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 623.71B | -5.27% |
| Dec 31, 2025 | 658.38B | -2.26% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Laurus Labs | 1.26T |
| Zydus Lifesciences | 1.19T |
| Cipla | 1.13T |
| Mankind Pharma | 1.05T |
| Aurobindo Pharma | 981.02B |
| Glenmark Pharmaceuticals | 706.83B |
| Gland Pharma | 518.26B |
| Ipca Laboratories | 500.43B |